 | Up a level |
2020
Knispel, Sarah, Stang, Andreas, Zimmer, Lisa, Lax, Hildegard, Gutzmer, Ralf, Heinzerling, Lucie, Weishaupt, Carsten, Pfoehler, Claudia, Gesierich, Anja, Herbst, Rudolf, Kaehler, Katharina C., Weide, Benjamin, Berking, Carola, Loquai, Carmen, Utikal, Jochen, Terheyden, Patrick, Kaatz, Martin, Schlaak, Max, Kreuter, Alexander, Ulrich, Jens, Mohr, Peter, Dippel, Edgar, Livingstone, Elisabeth, Becker, Juergen C., Weichenthal, Michael, Chorti, Eleftheria, Gronewold, Janine, Schadendorf, Dirk and Ugurel, Selma (2020). Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG. J. Immunother. Cancer, 8 (1). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
2017
Heppt, Markus V., Roesch, Alexander, Weide, Benjamin, Gutzmer, Ralf, Meier, Friedegund, Loquai, Carmen, Kaehler, Katharina C., Gesierich, Anja, Meissner, Markus, von Bubnoff, Dagmar, Goeppner, Daniela, Schlaak, Max, Pfoehler, Claudia, Utikal, Jochen 
ORCID: 0000-0001-5316-0241, Heinzerling, Lucie, Cosgarea, Ioana, Engel, Jutta, Eckel, Renate, Martens, Alexander, Mirlach, Laura, Satzger, Imke, Schubert-Fritschle, Gabriele, Tietze, Julia K. and Berking, Carola
(2017).
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Eur. J. Cancer, 81.
S. 36 - 45.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
2016
Weide, Benjamin, Martens, Alexander, Hassel, Jessica C., Berking, Carola, Postow, Michael A., Bisschop, Kees, Simeone, Ester, Mangana, Johanna, Schilling, Bastian ORCID: 0000-0001-8859-4103, Di Giacomo, Anna Maria, Brenner, Nicole, Kaehler, Katharina, Heinzerling, Lucie, Gutzmer, Ralf, Bender, Armin, Gebhardt, Christoffer ORCID: 0000-0001-7090-9584, Romano, Emanuela, Meier, Friedegund, Martus, Peter, Maio, Michele ORCID: 0000-0002-0323-6321, Blank, Christian, Schadendorf, Dirk, Dummer, Reinhard, Ascierto, Paolo A., Hospers, Geke, Garbe, Claus ORCID: 0000-0001-8530-780X and Wolchok, Jedd D.
(2016).
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Clin. Cancer Res., 22 (22).
S. 5487 - 5497.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265